Cancers, Free Full-Text

Por um escritor misterioso

Descrição

Neuroblastoma is the most common extracranial solid pediatric tumor, with around 15% childhood cancer-related mortality. High-risk neuroblastomas exhibit a range of genetic, morphological, and clinical heterogeneities, which add complexity to diagnosis and treatment with existing modalities. Identification of novel therapies is a high priority in high-risk neuroblastoma, and the combination of genetic analysis with increased mechanistic understanding—including identification of key signaling and developmental events—provides optimism for the future. This focused review highlights several recent findings concerning chromosomes 1p, 2p, and 11q, which link genetic aberrations with aberrant molecular signaling output. These novel molecular insights contribute important knowledge towards more effective treatment strategies for neuroblastoma.
Cancers, Free Full-Text
Remission, cancer-free, no evidence of disease: What's the difference?
Cancers, Free Full-Text
Classification of biliary tract cancers established by JSHBPS: 3rd English edition|Japanese Society of Hepato-Biliary-Pancreatic Surgery
Cancers, Free Full-Text
What Types of Cancers Are Caused by Asbestos?
Cancers, Free Full-Text
Pancreatic Cancer Action Network – Research, Patient Support, Resources
Cancers, Free Full-Text
Cancers, Free Full-Text
Cancers, Free Full-Text
Home - Free ME from Lung Cancer
Cancers, Free Full-Text
Cancer Cells: Types, How They Form, and Characteristics
Cancers, Free Full-Text
from Flow Cytometry to Cytomics, Page 2
Cancers, Free Full-Text
Mortality after second malignancy in breast cancer survivors compared to a first primary cancer: a nationwide longitudinal cohort study
Cancers, Free Full-Text
O Amar Mota Bou Get File - Colaboratory
Cancers, Free Full-Text
Noninvasive detection of any-stage cancer using free glycosaminoglycans
Cancers, Free Full-Text
The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019 - The Lancet
de por adulto (o preço varia de acordo com o tamanho do grupo)